Jazz Pharmaceuticals
Clinical trials sponsored by Jazz Pharmaceuticals, explained in plain language.
-
Major trial tests new drug combo against aggressive stomach cancers
Disease control OngoingThis large Phase 3 study is testing whether a new drug combination works better than the current standard treatment for advanced HER2-positive stomach and esophageal cancers that cannot be removed by surgery. The trial will involve 920 patients and compares zanidatamab plus chemo…
Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Safety check: does a seizure drug harm the liver over time?
Disease control OngoingThis study aims to monitor the long-term safety of Epidiolex (cannabidiol), a prescription medication for severe seizure disorders. It will check if long-term use causes chronic liver injury or scarring in 154 participants who are already taking or starting the drug. The main goa…
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Cannabis-Derived drug tested for brain symptoms in rare genetic disorder
Symptom relief OngoingThis study is checking if adding the prescription CBD medication Epidiolex to existing anti-seizure drugs helps improve behavior problems, sleep, and quality of life in people with tuberous sclerosis complex (TSC). It will include up to 79 participants, aged 1 to 65, who have TSC…
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Mar 11, 2026 14:53 UTC